Previous close | 85.22 |
Open | 85.38 |
Bid | 84.00 x 800 |
Ask | 85.03 x 1300 |
Day's range | 84.51 - 85.40 |
52-week range | 79.09 - 94.26 |
Volume | |
Avg. volume | 2,105,387 |
Market cap | 185.431B |
Beta (5Y monthly) | 0.49 |
PE ratio (TTM) | 8.33 |
EPS (TTM) | 10.20 |
Earnings date | N/A |
Forward dividend & yield | 3.33 (3.89%) |
Ex-dividend date | 08 Mar 2022 |
1y target est | 102.00 |
Novartis (NVS) suffers a setback as canakinumab fails to meet the primary goal in yet another study for lung cancer.
Bausch (BHC) will appeal to the U.S. Court of Appeals for the Federal Circuit regarding the patent decision for one of its key drugs Xifaxan.
Ionis (IONS) incurs a wider-than-expected loss in Q2. Its sales also miss estimates. Stock moves down in response to the results.